Management of infectious complications following liver transplantation.
Keating
M R
MR
Mayo Medical School, Rochester, Minnesota.
Wilhelm
M P
MP
D000890:Anti-Infective Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology / Q000628:therapy; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000628:therapy; D006525:Hepatitis, Viral, Human / Q000209:etiology / Q000628:therapy; D006566:Herpesviridae Infections / Q000209:etiology / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D017053:Infection Control; D007239:Infections / Q000209:etiology* / Q000628:therapy*; D016031:Liver Transplantation / Q000009:adverse effects*; D009181:Mycoses / Q000209:etiology / Q000628:therapy; D013997:Time Factors
D000890:Anti-Infective Agents